@prefix ns1: <http://example.org/> .
@prefix ns2: <http://example.org/relation/> .

<http://example.org/doc/samplepdf> a ns1:Document ;
    ns1:contains <http://example.org/entity/001_value>,
        <http://example.org/entity/008_value>,
        <http://example.org/entity/238_value>,
        <http://example.org/entity/251_value>,
        <http://example.org/entity/60_month_EFS_500_ml_data_point>,
        <http://example.org/entity/60_month_EFS_AVD_500_ml_data_point>,
        <http://example.org/entity/60_month_EFS_AV_2_500_ml_data_point>,
        <http://example.org/entity/60_month_OS_500_ml_data_point>,
        <http://example.org/entity/60_month_OS_AVD_500_ml_data_point>,
        <http://example.org/entity/60_month_OS_AV_2_500_ml_data_point>,
        <http://example.org/entity/800_value>,
        <http://example.org/entity/903_value>,
        <http://example.org/entity/931_value>,
        <http://example.org/entity/967_value>,
        <http://example.org/entity/AREN0533_study>,
        <http://example.org/entity/Actinomycin_D_drug>,
        <http://example.org/entity/Albania_Country>,
        <http://example.org/entity/Algeria_Country>,
        <http://example.org/entity/Andorra_Country>,
        <http://example.org/entity/Ann_Oncol_23_journal>,
        <http://example.org/entity/Ann_Surg_254_journal>,
        <http://example.org/entity/Anne_M_Smets_author>,
        <http://example.org/entity/Armand_Trousseau_Hospital_Institution>,
        <http://example.org/entity/Arnauld_C_Verschuur_author>,
        <http://example.org/entity/Austria_Country>,
        <http://example.org/entity/Azienda_Ospedaliera_Padova_Institution>,
        <http://example.org/entity/Beatriz_de_Camargo_author>,
        <http://example.org/entity/Belgium_Country>,
        <http://example.org/entity/Bilateral_Wilms_tumours_condition>,
        <http://example.org/entity/Bosnia_and_Herzegovina_Country>,
        <http://example.org/entity/Breslow_N_E_author>,
        <http://example.org/entity/Bulgaria_Country>,
        <http://example.org/entity/COGNWTS_trials_Study>,
        <http://example.org/entity/CT_only_nodules_condition_component>,
        <http://example.org/entity/Cancer_101_journal>,
        <http://example.org/entity/Cancer_64_journal>,
        <http://example.org/entity/Carboplatin_drug>,
        <http://example.org/entity/Childrens_Oncology_Group_COG_organization>,
        <http://example.org/entity/Childrens_Oncology_Group_study_group>,
        <http://example.org/entity/Christian_R%C3%BCbe_author>,
        <http://example.org/entity/Christophe_Bergeron_author>,
        <http://example.org/entity/Croatia_Country>,
        <http://example.org/entity/Cyclophosphamide_drug>,
        <http://example.org/entity/Czech_Republic_Country>,
        <http://example.org/entity/DAngio_G_J_author>,
        <http://example.org/entity/Davila_Fajardo_Person>,
        <http://example.org/entity/Denmark_Country>,
        <http://example.org/entity/Dix_D_B_author>,
        <http://example.org/entity/Dome_J_S_author>,
        <http://example.org/entity/Doxorubicin_drug>,
        <http://example.org/entity/EFS_probability_measure>,
        <http://example.org/entity/EFS_probability_metric>,
        <http://example.org/entity/EFSt_Survival_Rate>,
        <http://example.org/entity/End_stage_renal_disease_ESRD_condition>,
        <http://example.org/entity/Estonia_Country>,
        <http://example.org/entity/Etoposide_drug>,
        <http://example.org/entity/Eur_J_Cancer_42_journal>,
        <http://example.org/entity/Eur_J_Cancer_48_journal>,
        <http://example.org/entity/Eur_J_Cancer_51_journal>,
        <http://example.org/entity/European_Expert_Paediatric_Oncology_Reference_Network_for_Diagnostics_and_Treatment_Organization>,
        <http://example.org/entity/ExPO_r_Net_Project>,
        <http://example.org/entity/Expert_Rev_Anticancer_Ther_6_journal>,
        <http://example.org/entity/Faculty_of_Medicine_Gdansk_Institution>,
        <http://example.org/entity/Filippo_Spreafico_author>,
        <http://example.org/entity/Finland_Country>,
        <http://example.org/entity/Fondazione_IRCCS_Istituto_Nazionale_dei_Tumori_Institution>,
        <http://example.org/entity/France_Country>,
        <http://example.org/entity/Geert_O_Janssens_author>,
        <http://example.org/entity/Gema_L_Ram%C3%ADrez_Villar_author>,
        <http://example.org/entity/Germany_Country>,
        <http://example.org/entity/Gordan_M_Vujanic_author>,
        <http://example.org/entity/Graf_N_author>,
        <http://example.org/entity/Great_Ormond_Street_Hospital_Institution>,
        <http://example.org/entity/Greece_Country>,
        <http://example.org/entity/Green_D_M_author>,
        <http://example.org/entity/Group_AA_classification>,
        <http://example.org/entity/Group_BB_classification>,
        <http://example.org/entity/Group_CC_classification>,
        <http://example.org/entity/Grundy_P_E_author>,
        <http://example.org/entity/HR_1_treatment_protocol>,
        <http://example.org/entity/HR_metric>,
        <http://example.org/entity/Harm_van_Tinteren_author>,
        <http://example.org/entity/Heidi_Segers_author>,
        <http://example.org/entity/High_dose_melphalan_drug>,
        <http://example.org/entity/Hospital_Universitario_Virgin_del_Rocio_Institution>,
        <http://example.org/entity/Hospital_Vall_dHebron_Institution>,
        <http://example.org/entity/Hungary_Country>,
        <http://example.org/entity/Iceland_Country>,
        <http://example.org/entity/Ifosfamide_drug>,
        <http://example.org/entity/Innovative_Therapies_for_Children_with_Cancer_consortium_organization>,
        <http://example.org/entity/Ireland_Country>,
        <http://example.org/entity/Italy_Country>,
        <http://example.org/entity/Ivo_Leuschner_author>,
        <http://example.org/entity/J_Clin_Oncol_19_journal>,
        <http://example.org/entity/J_Clin_Oncol_33_journal>,
        <http://example.org/entity/Jan_Godzinski_author>,
        <http://example.org/entity/Janna_A_Hol_author>,
        <http://example.org/entity/Jesper_Brok_author>,
        <http://example.org/entity/Kathy_Pritchard_Jones_author>,
        <http://example.org/entity/Kosovo_Country>,
        <http://example.org/entity/LInstitut_dH%C3%A9matologie_et_dOncologie_P%C3%A9diatrique_de_Lyon_Institution>,
        <http://example.org/entity/Lancet_364_journal>,
        <http://example.org/entity/Latvia_Country>,
        <http://example.org/entity/Lithuania_Country>,
        <http://example.org/entity/LogRank_P_statistic>,
        <http://example.org/entity/Luxembourg_Country>,
        <http://example.org/entity/Macedonia_Country>,
        <http://example.org/entity/Malta_Country>,
        <http://example.org/entity/Manfred_Gessler_author>,
        <http://example.org/entity/Marciniak_Hospital_Institution>,
        <http://example.org/entity/Marry_M_van_den_Heuvel_Eibrink_author>,
        <http://example.org/entity/Mitchell_C_author>,
        <http://example.org/entity/Monaco_Country>,
        <http://example.org/entity/Montenegro_Country>,
        <http://example.org/entity/Morocco_Country>,
        <http://example.org/entity/NSS_Surgery_Type>,
        <http://example.org/entity/NSS_surgical_technique>,
        <http://example.org/entity/NWTS_4_study>,
        <http://example.org/entity/NWTS_5_relapse_protocol_treatment_protocol>,
        <http://example.org/entity/NWTS_5_study>,
        <http://example.org/entity/National_Wilms_Tumor_Study_Group_study_group>,
        <http://example.org/entity/Nephron_sparing_surgery_NSS_treatment>,
        <http://example.org/entity/Netherlands_Country>,
        <http://example.org/entity/Norbert_Graf_author>,
        <http://example.org/entity/Norway_Country>,
        <http://example.org/entity/OS_Survival_Rate>,
        <http://example.org/entity/OS_probability_measure>,
        <http://example.org/entity/OS_probability_metric>,
        <http://example.org/entity/Ospedale_Pediatrico_Bambino_Ges%C3%B9_Institution>,
        <http://example.org/entity/Paola_Collini_author>,
        <http://example.org/entity/Pediatr_Blood_Cancer_55_journal>,
        <http://example.org/entity/Pediatr_Blood_Cancer_59_journal>,
        <http://example.org/entity/Pediatr_Blood_Cancer_61_journal>,
        <http://example.org/entity/Poland_Country>,
        <http://example.org/entity/Portugal_Country>,
        <http://example.org/entity/Prinses_Maxima_Centrum_Institution>,
        <http://example.org/entity/Pritchard_Jones_K_author>,
        <http://example.org/entity/Relapsed_Wilms_tumour_condition>,
        <http://example.org/entity/Rhoikos_Furtw%C3%A4ngler_author>,
        <http://example.org/entity/Russia_Country>,
        <http://example.org/entity/SIOP2001_Study>,
        <http://example.org/entity/SIOP2001_protocol_medical_protocol>,
        <http://example.org/entity/SIOP2001_randomized_controlled_trial_study>,
        <http://example.org/entity/SIOP2001_randomized_trial_clinical_trial>,
        <http://example.org/entity/SIOP9301_trial_trial>,
        <http://example.org/entity/SIOPRTSG_Organization>,
        <http://example.org/entity/SIOPRTSG_organization>,
        <http://example.org/entity/SIOPRTSG_panel_organization>,
        <http://example.org/entity/SIOP_2001_trial_trial>,
        <http://example.org/entity/SIOP_9301_trial_trial>,
        <http://example.org/entity/SIOP_database_database>,
        <http://example.org/entity/SIOP_organization>,
        <http://example.org/entity/San_Marino_Country>,
        <http://example.org/entity/Serbia_Country>,
        <http://example.org/entity/Slovakia_Country>,
        <http://example.org/entity/Slovenia_Country>,
        <http://example.org/entity/Smets_A_M_author>,
        <http://example.org/entity/Spain_Country>,
        <http://example.org/entity/Spreafico_F_author>,
        <http://example.org/entity/St_Anna_KinderspitalCCRI_Institution>,
        <http://example.org/entity/Sweden_Country>,
        <http://example.org/entity/Switzerland_Country>,
        <http://example.org/entity/Terenziani_M_author>,
        <http://example.org/entity/Tournade_M_F_author>,
        <http://example.org/entity/Tunisia_Country>,
        <http://example.org/entity/Turkey_Country>,
        <http://example.org/entity/UKW3_trial_clinical_trial>,
        <http://example.org/entity/UKW3_trial_trial>,
        <http://example.org/entity/UKW_R_protocol_treatment_protocol>,
        <http://example.org/entity/UK_Childrens_Cancer_Study_Group_study_group>,
        <http://example.org/entity/UK_Childrens_Cancer_and_Leukaemia_Group_UKCCLG_organization>,
        <http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_medical_protocol>,
        <http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_protocol>,
        <http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_source>,
        <http://example.org/entity/UMBRELLA_protocol_Project>,
        <http://example.org/entity/UMBRELLA_protocol_Protocol>,
        <http://example.org/entity/UMBRELLA_protocol_protocol>,
        <http://example.org/entity/UMBRELLA_protocol_treatment_protocol>,
        <http://example.org/entity/United_Kingdom_Country>,
        <http://example.org/entity/University_Hospital_Homburg_Institution>,
        <http://example.org/entity/University_Hospital_of_Munich_Institution>,
        <http://example.org/entity/University_Hospital_of_Tuebingen_Institution>,
        <http://example.org/entity/Verschuur_A_author>,
        <http://example.org/entity/Vincristine_drug>,
        <http://example.org/entity/Warmann_S_W_author>,
        <http://example.org/entity/Weirich_A_author>,
        <http://example.org/entity/Wilms_tumour_clinical_condition>,
        <http://example.org/entity/Wilms_tumour_condition>,
        <http://example.org/entity/Wilms_tumour_disease>,
        <http://example.org/entity/Wilms_tumour_histology_classification>,
        <http://example.org/entity/Wilms_tumours_Disease>,
        <http://example.org/entity/Wilms_tumours_condition>,
        <http://example.org/entity/actinomycin_D_drug>,
        <http://example.org/entity/actinomycin_D_medication>,
        <http://example.org/entity/adult_Wilms_tumours_disease>,
        <http://example.org/entity/autologous_stem_cell_rescue_ASCR_treatment>,
        <http://example.org/entity/blastemal_component_medical_term>,
        <http://example.org/entity/blastemal_type_Wilms_tumour_clinical_condition>,
        <http://example.org/entity/blastemal_type_Wilms_tumours_condition_subcategory>,
        <http://example.org/entity/camptothecins_irinotecan_or_topotecan_treatment>,
        <http://example.org/entity/carboplatin_and_etoposide_treatment>,
        <http://example.org/entity/carboplatin_drug>,
        <http://example.org/entity/chemotherapy_resistant_disease_condition_detail>,
        <http://example.org/entity/chemotherapy_treatment>,
        <http://example.org/entity/chemotherapy_treatment_method>,
        <http://example.org/entity/clear_cell_sarcoma_of_the_kidney_CCSK_clinical_condition>,
        <http://example.org/entity/clear_cell_sarcoma_of_the_kidney_disease>,
        <http://example.org/entity/complete_remission_treatment_response>,
        <http://example.org/entity/completely_necrotic_metastasis_condition_detail>,
        <http://example.org/entity/confirm_metastatic_disease_by_histology_treatment>,
        <http://example.org/entity/congenital_mesoblastic_nephroma_CMN_clinical_condition>,
        <http://example.org/entity/congenital_mesoblastic_nephroma_disease>,
        <http://example.org/entity/cyclophosphamide_and_etoposide_treatment>,
        <http://example.org/entity/cyclophosphamide_drug>,
        <http://example.org/entity/de_Kraker_J_author>,
        <http://example.org/entity/doxorubicin_drug>,
        <http://example.org/entity/doxorubicin_medication>,
        <http://example.org/entity/enucleation_surgical_technique>,
        <http://example.org/entity/epithelial_tumour_types_clinical_condition>,
        <http://example.org/entity/etoposide_drug>,
        <http://example.org/entity/event_free_survival_EFS_outcome>,
        <http://example.org/entity/flank_Anatomical_Structure>,
        <http://example.org/entity/focal_anaplasia_type_tumours_clinical_condition>,
        <http://example.org/entity/genomic_changes_biological_factor>,
        <http://example.org/entity/high_dose_chemotherapy_treatment>,
        <http://example.org/entity/high_risk_Risk_Category>,
        <http://example.org/entity/high_risk_disease_classification_subgroup>,
        <http://example.org/entity/ifosfamide_treatment>,
        <http://example.org/entity/infant_Wilms_tumours_disease>,
        <http://example.org/entity/intermediate_risk_Risk_Category>,
        <http://example.org/entity/intermediate_risk_disease_classification_subgroup>,
        <http://example.org/entity/laparoscopic_surgery_Surgery_Type>,
        <http://example.org/entity/large_volume_tumours_clinical_condition>,
        <http://example.org/entity/locoregional_disease_Disease_Category>,
        <http://example.org/entity/low_risk_Risk_Category>,
        <http://example.org/entity/low_risk_disease_classification_subgroup>,
        <http://example.org/entity/lung_nodules_35mm_condition_detail>,
        <http://example.org/entity/lung_nodules_5mm_condition_detail>,
        <http://example.org/entity/malignant_rhabdoid_tumour_of_the_kidney_MRTK_clinical_condition>,
        <http://example.org/entity/malignant_rhabdoid_tumour_of_the_kidney_disease>,
        <http://example.org/entity/malignant_rhabdoid_tumours_disease>,
        <http://example.org/entity/metastasis_surgery_treatment>,
        <http://example.org/entity/metastatic_disease_Disease_Category>,
        <http://example.org/entity/metastatic_disease_stage_IV_clinical_condition>,
        <http://example.org/entity/metastatic_sites_Anatomical_Structure>,
        <http://example.org/entity/minimally_invasive_surgery_Surgery_Type>,
        <http://example.org/entity/mixed_clinical_condition>,
        <http://example.org/entity/no_evidence_of_metastasis_condition_detail>,
        <http://example.org/entity/no_evidence_of_viable_tumour_condition_detail>,
        <http://example.org/entity/non_Wilms_tumours_disease>,
        <http://example.org/entity/novel_compounds_treatment_option>,
        <http://example.org/entity/overall_survival_outcome>,
        <http://example.org/entity/partial_nephrectomy_surgical_technique>,
        <http://example.org/entity/partial_response_treatment_response>,
        <http://example.org/entity/preoperative_chemotherapy_treatment>,
        <http://example.org/entity/progressive_disease_treatment_response>,
        <http://example.org/entity/proton_therapy_Treatment>,
        <http://example.org/entity/pulmonary_radiotherapy_Treatment>,
        <http://example.org/entity/radiotherapy_Treatment>,
        <http://example.org/entity/radiotherapy_treatment>,
        <http://example.org/entity/radiotherapy_treatment_method>,
        <http://example.org/entity/relapsing_patients_patient_group>,
        <http://example.org/entity/renal_cell_carcinoma_RCC_clinical_condition>,
        <http://example.org/entity/renal_cell_carcinoma_disease>,
        <http://example.org/entity/renal_tumour_patients_patient_group>,
        <http://example.org/entity/renal_tumours_disease>,
        <http://example.org/entity/representative_nodule_resection_treatment>,
        <http://example.org/entity/small_volume_tumours_clinical_condition>,
        <http://example.org/entity/stable_disease_treatment_response>,
        <http://example.org/entity/stage_IIIII_regressive_clinical_condition>,
        <http://example.org/entity/stage_IV_WT_condition>,
        <http://example.org/entity/stromal_tumour_types_clinical_condition>,
        <http://example.org/entity/surgery_treatment>,
        <http://example.org/entity/surgery_treatment_method>,
        <http://example.org/entity/surgical_complete_resection_treatment>,
        <http://example.org/entity/van_den_Heuvel_Eibrink_M_M_author>,
        <http://example.org/entity/very_good_partial_remission_treatment_response>,
        <http://example.org/entity/viable_metastasis_condition_detail>,
        <http://example.org/entity/vincristine_and_actinomycin_D_plus_doxorubicin_treatment>,
        <http://example.org/entity/vincristine_and_actinomycin_D_treatment>,
        <http://example.org/entity/vincristine_drug>,
        <http://example.org/entity/vincristine_medication>,
        <http://example.org/entity/whole_abdominal_radiotherapy_Treatment>,
        <http://example.org/entity/whole_lung_irradiation_Treatment>,
        <http://example.org/entity/wwwsiop_rtsgeu_website> .

<http://example.org/entity/60_month_EFS_500_ml_entity> ns2:has_value <http://example.org/entity/800_entity>,
        <http://example.org/entity/903_entity> .

<http://example.org/entity/60_month_OS_500_ml_entity> ns2:has_value <http://example.org/entity/931_entity>,
        <http://example.org/entity/967_entity> .

<http://example.org/entity/Actinomycin_D_entity> ns2:treatment_for <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/Breslow_N_E_entity> ns2:published_in <http://example.org/entity/Cancer_101_entity> .

<http://example.org/entity/Carboplatin_entity> ns2:treatment_for <http://example.org/entity/Relapsed_Wilms_tumour_entity> .

<http://example.org/entity/Cyclophosphamide_entity> ns2:treatment_for <http://example.org/entity/Relapsed_Wilms_tumour_entity> .

<http://example.org/entity/DAngio_G_J_entity> ns2:published_in <http://example.org/entity/Cancer_64_entity> .

<http://example.org/entity/Davila_Fajardo_entity> ns2:analysis_no_benefit <http://example.org/entity/radiotherapy_entity> .

<http://example.org/entity/Dix_D_B_entity> ns2:published_in <http://example.org/entity/J_Clin_Oncol_32_entity> .

<http://example.org/entity/Dome_J_S_entity> ns2:published_in <http://example.org/entity/J_Clin_Oncol_33_entity> .

<http://example.org/entity/Doxorubicin_entity> ns2:treatment_for <http://example.org/entity/Relapsed_Wilms_tumour_entity> .

<http://example.org/entity/EFS_probability_entity> ns2:associated_metric <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/Etoposide_entity> ns2:treatment_for <http://example.org/entity/Relapsed_Wilms_tumour_entity> .

<http://example.org/entity/European_initiatives_entity> ns2:include <http://example.org/entity/ExPO_r_Net_entity> .

<http://example.org/entity/Graf_N_entity> ns2:published_in <http://example.org/entity/Eur_J_Cancer_48_entity> .

<http://example.org/entity/Green_D_M_entity> ns2:contributed_to <http://example.org/entity/National_Wilms_Tumor_Study_Group_entity> ;
    ns2:published_in <http://example.org/entity/Pediatr_Blood_Cancer_61_entity> .

<http://example.org/entity/Group_AA_entity> ns2:classification_of <http://example.org/entity/Relapsed_Wilms_tumour_entity> .

<http://example.org/entity/Group_BB_entity> ns2:classification_of <http://example.org/entity/Relapsed_Wilms_tumour_entity> .

<http://example.org/entity/Group_CC_entity> ns2:classification_of <http://example.org/entity/Relapsed_Wilms_tumour_entity> .

<http://example.org/entity/Grundy_P_E_entity> ns2:published_in <http://example.org/entity/Pediatr_Blood_Cancer_59_entity> ;
    ns2:reported_to <http://example.org/entity/Childrens_Oncology_Group_entity> .

<http://example.org/entity/HR_entity> ns2:has_value <http://example.org/entity/238_entity>,
        <http://example.org/entity/251_entity> .

<http://example.org/entity/High_dose_melphalan_entity> ns2:treatment_for <http://example.org/entity/Relapsed_Wilms_tumour_entity> .

<http://example.org/entity/Ifosfamide_entity> ns2:treatment_for <http://example.org/entity/Relapsed_Wilms_tumour_entity> .

<http://example.org/entity/LogRank_P_entity> ns2:has_value <http://example.org/entity/001_entity>,
        <http://example.org/entity/008_entity> .

<http://example.org/entity/Mitchell_C_entity> ns2:contributed_to <http://example.org/entity/UK_Childrens_Cancer_Study_Group_entity> ;
    ns2:published_in <http://example.org/entity/Eur_J_Cancer_42_entity> .

<http://example.org/entity/NWTS_5_relapse_protocol_entity> ns2:treatment_for <http://example.org/entity/Relapsed_Wilms_tumour_entity> .

<http://example.org/entity/Nephron_sparing_surgery_NSS_entity> ns2:treatment_for <http://example.org/entity/Bilateral_Wilms_tumours_entity> .

<http://example.org/entity/Norbert_Graf_entity> ns2:contributed_to <http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_entity> .

<http://example.org/entity/OS_probability_entity> ns2:associated_metric <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/Pritchard_Jones_K_entity> ns2:analyzed_cases_in <http://example.org/entity/UKW3_trial_entity> ;
    ns2:published_in <http://example.org/entity/Ann_Oncol_23_entity> .

<http://example.org/entity/SIOP2001_entity> ns2:related_study <http://example.org/entity/radiotherapy_entity> .

<http://example.org/entity/SIOP2001_protocol_entity> ns2:preceded_by <http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_entity> .

<http://example.org/entity/SIOP2001_randomized_controlled_trial_entity> ns2:focuses_on <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/SIOP2001_randomized_trial_entity> ns2:investigated_usage_of <http://example.org/entity/doxorubicin_entity> .

<http://example.org/entity/SIOPRTSG_entity> ns2:addresses <http://example.org/entity/geographic_inequalities_in_childhood_cancer_survival_entity> .

<http://example.org/entity/SIOP_entity> ns2:SIOPRTSG <http://example.org/entity/vested_in_entity> .

<http://example.org/entity/Smets_A_M_entity> ns2:published_in <http://example.org/entity/Eur_J_Cancer_48_entity> .

<http://example.org/entity/Spreafico_F_entity> ns2:published_in <http://example.org/entity/Expert_Rev_Anticancer_Ther_6_entity> .

<http://example.org/entity/Terenziani_M_entity> ns2:published_in <http://example.org/entity/Cancer_101_entity> .

<http://example.org/entity/Tournade_M_F_entity> ns2:published_in <http://example.org/entity/J_Clin_Oncol_19_entity> .

<http://example.org/entity/UKW_R_protocol_entity> ns2:treatment_for <http://example.org/entity/Relapsed_Wilms_tumour_entity> .

<http://example.org/entity/UK_Childrens_Cancer_and_Leukaemia_Group_UKCCLG_entity> ns2:conducted <http://example.org/entity/UKW3_trial_entity> .

<http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_entity> ns2:recommends_inclusion_of <http://example.org/entity/doxorubicin_entity> .

<http://example.org/entity/Verschuur_A_entity> ns2:published_in <http://example.org/entity/Pediatr_Blood_Cancer_55_entity> .

<http://example.org/entity/Vincristine_entity> ns2:treatment_for <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/Warmann_S_W_entity> ns2:published_in <http://example.org/entity/Ann_Surg_254_entity> .

<http://example.org/entity/Weirich_A_entity> ns2:contributed_to <http://example.org/entity/AREN0533_entity> .

<http://example.org/entity/actinomycin_D_entity> ns2:used_for <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/autologous_stem_cell_rescue_ASCR_entity> ns2:is_treatment_for <http://example.org/entity/relapsing_patients_entity> .

<http://example.org/entity/blastemal_type_Wilms_tumour_entity> ns2:continues_treatment <http://example.org/entity/treatment_entity> .

<http://example.org/entity/blastemal_type_Wilms_tumours_entity> ns2:subtype_of <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/camptothecins_irinotecan_or_topotecan_entity> ns2:is_treatment_for <http://example.org/entity/relapsing_patients_entity> .

<http://example.org/entity/carboplatin_and_etoposide_entity> ns2:is_treatment_for <http://example.org/entity/relapsing_patients_entity> .

<http://example.org/entity/confirm_metastatic_disease_by_histology_entity> ns2:is_indicated_for <http://example.org/entity/high_risk_disease_entity> .

<http://example.org/entity/congenital_mesoblastic_nephroma_entity> ns2:treatment_involves <http://example.org/entity/surgery_alone_entity> .

<http://example.org/entity/cyclophosphamide_and_etoposide_entity> ns2:is_treatment_for <http://example.org/entity/relapsing_patients_entity> .

<http://example.org/entity/de_Kraker_J_entity> ns2:conducted_study <http://example.org/entity/SIOP_9301_trial_entity> ;
    ns2:published_in <http://example.org/entity/Lancet_364_entity> .

<http://example.org/entity/flank_entity> ns2:target_of <http://example.org/entity/proton_therapy_entity> .

<http://example.org/entity/high_dose_chemotherapy_entity> ns2:is_treatment_for <http://example.org/entity/relapsing_patients_entity> .

<http://example.org/entity/high_risk_entity> ns2:indicated <http://example.org/entity/radiotherapy_entity> .

<http://example.org/entity/intermediate_risk_disease_entity> ns2:is_a_type_of <http://example.org/entity/Wilms_tumour_histology_entity> .

<http://example.org/entity/intermediate_risk_entity> ns2:indicated <http://example.org/entity/radiotherapy_entity> .

<http://example.org/entity/laparoscopic_surgery_entity> ns2:addressed_in <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/locoregional_disease_entity> ns2:treated_by <http://example.org/entity/radiotherapy_entity> .

<http://example.org/entity/low_risk_entity> ns2:not_indicated <http://example.org/entity/radiotherapy_entity> .

<http://example.org/entity/malignant_rhabdoid_tumours_entity> ns2:requires <http://example.org/entity/more_intensive_chemotherapy_entity> .

<http://example.org/entity/metastatic_disease_entity> ns2:treated_by <http://example.org/entity/radiotherapy_entity> .

<http://example.org/entity/metastatic_disease_stage_IV_entity> ns2:is_a_condition_of <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/metastatic_sites_entity> ns2:target_of <http://example.org/entity/radiotherapy_entity> .

<http://example.org/entity/minimally_invasive_surgery_entity> ns2:addressed_in <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/pulmonary_radiotherapy_entity> ns2:administered_for <http://example.org/entity/lung_metastases_entity> .

<http://example.org/entity/representative_nodule_resection_entity> ns2:is_treatment_for <http://example.org/entity/partial_response_entity> .

<http://example.org/entity/small_volume_tumours_entity> ns2:associated_with_higher <http://example.org/entity/event_free_survival_EFS_entity> .

<http://example.org/entity/stage_IV_WT_entity> ns2:is_classified_by <http://example.org/entity/Wilms_tumour_histology_entity> .

<http://example.org/entity/surgical_complete_resection_entity> ns2:is_treatment_for <http://example.org/entity/low_risk_disease_entity> .

<http://example.org/entity/van_den_Heuvel_Eibrink_M_M_entity> ns2:published_in <http://example.org/entity/Eur_J_Cancer_51_entity> .

<http://example.org/entity/vincristine_and_actinomycin_D_without_doxorubicin_entity> ns2:associated_with <http://example.org/entity/event_free_survival_EFS_entity> ;
    ns2:no_effect_on <http://example.org/entity/overall_survival_entity> .

<http://example.org/entity/vincristine_entity> ns2:used_for <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/whole_abdominal_radiotherapy_entity> ns2:indicated_for <http://example.org/entity/tumour_rupture_entity> .

<http://example.org/entity/whole_lung_irradiation_entity> ns2:used_for <http://example.org/entity/lung_metastases_entity> .

<http://example.org/entity/001_value> a ns1:value ;
    ns1:name "0.01" .

<http://example.org/entity/008_value> a ns1:value ;
    ns1:name "0.08" .

<http://example.org/entity/238_value> a ns1:value ;
    ns1:name "2.38" .

<http://example.org/entity/251_value> a ns1:value ;
    ns1:name "2.51" .

<http://example.org/entity/60_month_EFS_500_ml_data_point> a ns1:data_point ;
    ns1:name "60-month EFS – 500+ ml",
        "60-month EFS – <500 ml" .

<http://example.org/entity/60_month_EFS_AVD_500_ml_data_point> a ns1:data_point ;
    ns1:name "60-month EFS - AVD. 500+ ml",
        "60-month EFS - AVD. <500 ml" .

<http://example.org/entity/60_month_EFS_AV_2_500_ml_data_point> a ns1:data_point ;
    ns1:name "60-month EFS - AV-2. 500+ ml",
        "60-month EFS - AV-2. <500 ml" .

<http://example.org/entity/60_month_OS_500_ml_data_point> a ns1:data_point ;
    ns1:name "60-month OS – 500+ ml",
        "60-month OS – <500 ml" .

<http://example.org/entity/60_month_OS_AVD_500_ml_data_point> a ns1:data_point ;
    ns1:name "60-month OS - AVD. 500+ ml",
        "60-month OS - AVD. <500 ml" .

<http://example.org/entity/60_month_OS_AV_2_500_ml_data_point> a ns1:data_point ;
    ns1:name "60-month OS - AV-2. 500+ ml",
        "60-month OS - AV-2. <500 ml" .

<http://example.org/entity/800_value> a ns1:value ;
    ns1:name "80.0" .

<http://example.org/entity/903_value> a ns1:value ;
    ns1:name "90.3" .

<http://example.org/entity/931_value> a ns1:value ;
    ns1:name "93.1" .

<http://example.org/entity/967_value> a ns1:value ;
    ns1:name "96.7" .

<http://example.org/entity/AREN0533_study> a ns1:study ;
    ns1:name "AREN0533" .

<http://example.org/entity/Actinomycin_D_drug> a ns1:drug ;
    ns1:name "Actinomycin D" .

<http://example.org/entity/Albania_Country> a ns1:Country ;
    ns1:name "Albania" .

<http://example.org/entity/Algeria_Country> a ns1:Country ;
    ns1:name "Algeria" .

<http://example.org/entity/Andorra_Country> a ns1:Country ;
    ns1:name "Andorra" .

<http://example.org/entity/Ann_Oncol_23_journal> a ns1:journal ;
    ns1:name "Ann. Oncol. 23" .

<http://example.org/entity/Ann_Surg_254_journal> a ns1:journal ;
    ns1:name "Ann. Surg. 254" .

<http://example.org/entity/Anne_M_Smets_author> a ns1:author ;
    ns1:name "Anne M. Smets" .

<http://example.org/entity/Armand_Trousseau_Hospital_Institution> a ns1:Institution ;
    ns1:name "Armand Trousseau Hospital" .

<http://example.org/entity/Arnauld_C_Verschuur_author> a ns1:author ;
    ns1:name "Arnauld C. Verschuur" .

<http://example.org/entity/Austria_Country> a ns1:Country ;
    ns1:name "Austria" .

<http://example.org/entity/Azienda_Ospedaliera_Padova_Institution> a ns1:Institution ;
    ns1:name "Azienda Ospedaliera Padova" .

<http://example.org/entity/Beatriz_de_Camargo_author> a ns1:author ;
    ns1:name "Beatriz de Camargo" .

<http://example.org/entity/Belgium_Country> a ns1:Country ;
    ns1:name "Belgium" .

<http://example.org/entity/Bilateral_Wilms_tumours_condition> a ns1:condition ;
    ns1:name "Bilateral Wilms tumours" .

<http://example.org/entity/Bilateral_Wilms_tumours_entity> ns2:causes <http://example.org/entity/End_stage_renal_disease_ESRD_entity> .

<http://example.org/entity/Bosnia_and_Herzegovina_Country> a ns1:Country ;
    ns1:name "Bosnia and Herzegovina" .

<http://example.org/entity/Breslow_N_E_author> a ns1:author ;
    ns1:name "Breslow, N. E." .

<http://example.org/entity/Bulgaria_Country> a ns1:Country ;
    ns1:name "Bulgaria" .

<http://example.org/entity/COGNWTS_trials_Study> a ns1:Study ;
    ns1:name "COG–NWTS trials" .

<http://example.org/entity/CT_only_nodules_condition_component> a ns1:condition_component ;
    ns1:name "CT-only nodules" .

<http://example.org/entity/Cancer_101_journal> a ns1:journal ;
    ns1:name "Cancer 101" .

<http://example.org/entity/Cancer_64_journal> a ns1:journal ;
    ns1:name "Cancer 64" .

<http://example.org/entity/Carboplatin_drug> a ns1:drug ;
    ns1:name "Carboplatin" .

<http://example.org/entity/Childrens_Oncology_Group_COG_organization> a ns1:organization ;
    ns1:name "Children’s Oncology Group (COG)" .

<http://example.org/entity/Childrens_Oncology_Group_study_group> a ns1:study_group ;
    ns1:name "Children’s Oncology Group" .

<http://example.org/entity/Christian_R%C3%BCbe_author> a ns1:author ;
    ns1:name "Christian Rübe" .

<http://example.org/entity/Christophe_Bergeron_author> a ns1:author ;
    ns1:name "Christophe Bergeron" .

<http://example.org/entity/Croatia_Country> a ns1:Country ;
    ns1:name "Croatia" .

<http://example.org/entity/Cyclophosphamide_drug> a ns1:drug ;
    ns1:name "Cyclophosphamide" .

<http://example.org/entity/Czech_Republic_Country> a ns1:Country ;
    ns1:name "Czech Republic" .

<http://example.org/entity/DAngio_G_J_author> a ns1:author ;
    ns1:name "D’Angio, G. J." .

<http://example.org/entity/Davila_Fajardo_Person> a ns1:Person ;
    ns1:name "Davila Fajardo" .

<http://example.org/entity/Denmark_Country> a ns1:Country ;
    ns1:name "Denmark" .

<http://example.org/entity/Dix_D_B_author> a ns1:author ;
    ns1:name "Dix, D. B." .

<http://example.org/entity/Dome_J_S_author> a ns1:author ;
    ns1:name "Dome, J. S." .

<http://example.org/entity/Doxorubicin_drug> a ns1:drug ;
    ns1:name "Doxorubicin" .

<http://example.org/entity/EFS_probability_measure> a ns1:measure ;
    ns1:name "EFS probability" .

<http://example.org/entity/EFS_probability_metric> a ns1:metric ;
    ns1:name "EFS probability" .

<http://example.org/entity/EFSt_Survival_Rate> a ns1:Survival_Rate ;
    ns1:name "EFSt" .

<http://example.org/entity/End_stage_renal_disease_ESRD_condition> a ns1:condition ;
    ns1:name "End-stage renal disease (ESRD)" .

<http://example.org/entity/Estonia_Country> a ns1:Country ;
    ns1:name "Estonia" .

<http://example.org/entity/Etoposide_drug> a ns1:drug ;
    ns1:name "Etoposide" .

<http://example.org/entity/Eur_J_Cancer_42_journal> a ns1:journal ;
    ns1:name "Eur. J. Cancer 42" .

<http://example.org/entity/Eur_J_Cancer_48_journal> a ns1:journal ;
    ns1:name "Eur. J. Cancer 48" .

<http://example.org/entity/Eur_J_Cancer_51_journal> a ns1:journal ;
    ns1:name "Eur. J. Cancer 51" .

<http://example.org/entity/European_Expert_Paediatric_Oncology_Reference_Network_for_Diagnostics_and_Treatment_Organization> a ns1:Organization ;
    ns1:name "European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment" .

<http://example.org/entity/ExPO_r_Net_Project> a ns1:Project ;
    ns1:name "ExPO-r-Net" .

<http://example.org/entity/ExPO_r_Net_entity> ns2:is <http://example.org/entity/European_Expert_Paediatric_Oncology_Reference_Network_for_Diagnostics_and_Treatment_entity> .

<http://example.org/entity/Expert_Rev_Anticancer_Ther_6_journal> a ns1:journal ;
    ns1:name "Expert Rev. Anticancer Ther. 6" .

<http://example.org/entity/Faculty_of_Medicine_Gdansk_Institution> a ns1:Institution ;
    ns1:name "Faculty of Medicine Gdansk" .

<http://example.org/entity/Filippo_Spreafico_author> a ns1:author ;
    ns1:name "Filippo Spreafico" .

<http://example.org/entity/Finland_Country> a ns1:Country ;
    ns1:name "Finland" .

<http://example.org/entity/Fondazione_IRCCS_Istituto_Nazionale_dei_Tumori_Institution> a ns1:Institution ;
    ns1:name "Fondazione IRCCS Istituto Nazionale dei Tumori" .

<http://example.org/entity/France_Country> a ns1:Country ;
    ns1:name "France" .

<http://example.org/entity/Geert_O_Janssens_author> a ns1:author ;
    ns1:name "Geert O. Janssens" .

<http://example.org/entity/Gema_L_Ram%C3%ADrez_Villar_author> a ns1:author ;
    ns1:name "Gema L. Ramírez-Villar" .

<http://example.org/entity/Germany_Country> a ns1:Country ;
    ns1:name "Germany" .

<http://example.org/entity/Gordan_M_Vujanic_author> a ns1:author ;
    ns1:name "Gordan M. Vujanic" .

<http://example.org/entity/Graf_N_author> a ns1:author ;
    ns1:name "Graf, N." .

<http://example.org/entity/Great_Ormond_Street_Hospital_Institution> a ns1:Institution ;
    ns1:name "Great Ormond Street Hospital" .

<http://example.org/entity/Greece_Country> a ns1:Country ;
    ns1:name "Greece" .

<http://example.org/entity/Green_D_M_author> a ns1:author ;
    ns1:name "Green, D. M." .

<http://example.org/entity/Group_AA_classification> a ns1:classification ;
    ns1:name "Group AA" .

<http://example.org/entity/Group_BB_classification> a ns1:classification ;
    ns1:name "Group BB" .

<http://example.org/entity/Group_CC_classification> a ns1:classification ;
    ns1:name "Group CC" .

<http://example.org/entity/Grundy_P_E_author> a ns1:author ;
    ns1:name "Grundy, P. E." .

<http://example.org/entity/HR_1_treatment_protocol> a ns1:treatment_protocol ;
    ns1:name "HR-1" .

<http://example.org/entity/HR_metric> a ns1:metric ;
    ns1:name "HR" .

<http://example.org/entity/Harm_van_Tinteren_author> a ns1:author ;
    ns1:name "Harm van Tinteren" .

<http://example.org/entity/Heidi_Segers_author> a ns1:author ;
    ns1:name "Heidi Segers" .

<http://example.org/entity/High_dose_melphalan_drug> a ns1:drug ;
    ns1:name "High-dose melphalan" .

<http://example.org/entity/Hospital_Universitario_Virgin_del_Rocio_Institution> a ns1:Institution ;
    ns1:name "Hospital Universitario Virgin del Rocio" .

<http://example.org/entity/Hospital_Vall_dHebron_Institution> a ns1:Institution ;
    ns1:name "Hospital Vall d’Hebron" .

<http://example.org/entity/Hungary_Country> a ns1:Country ;
    ns1:name "Hungary" .

<http://example.org/entity/Iceland_Country> a ns1:Country ;
    ns1:name "Iceland" .

<http://example.org/entity/Ifosfamide_drug> a ns1:drug ;
    ns1:name "Ifosfamide" .

<http://example.org/entity/Innovative_Therapies_for_Children_with_Cancer_consortium_organization> a ns1:organization ;
    ns1:name "Innovative Therapies for Children with Cancer consortium" .

<http://example.org/entity/Ireland_Country> a ns1:Country ;
    ns1:name "Ireland" .

<http://example.org/entity/Italy_Country> a ns1:Country ;
    ns1:name "Italy" .

<http://example.org/entity/Ivo_Leuschner_author> a ns1:author ;
    ns1:name "Ivo Leuschner" .

<http://example.org/entity/J_Clin_Oncol_19_journal> a ns1:journal ;
    ns1:name "J. Clin. Oncol. 19" .

<http://example.org/entity/J_Clin_Oncol_33_journal> a ns1:journal ;
    ns1:name "J. Clin. Oncol. 33" .

<http://example.org/entity/Jan_Godzinski_author> a ns1:author ;
    ns1:name "Jan Godzinski" .

<http://example.org/entity/Janna_A_Hol_author> a ns1:author ;
    ns1:name "Janna A. Hol" .

<http://example.org/entity/Jesper_Brok_author> a ns1:author ;
    ns1:name "Jesper Brok" .

<http://example.org/entity/Kathy_Pritchard_Jones_author> a ns1:author ;
    ns1:name "Kathy Pritchard-Jones" .

<http://example.org/entity/Kosovo_Country> a ns1:Country ;
    ns1:name "Kosovo" .

<http://example.org/entity/LInstitut_dH%C3%A9matologie_et_dOncologie_P%C3%A9diatrique_de_Lyon_Institution> a ns1:Institution ;
    ns1:name "L’Institut d’Hématologie et d’Oncologie Pédiatrique de Lyon" .

<http://example.org/entity/Lancet_364_journal> a ns1:journal ;
    ns1:name "Lancet 364" .

<http://example.org/entity/Latvia_Country> a ns1:Country ;
    ns1:name "Latvia" .

<http://example.org/entity/Lithuania_Country> a ns1:Country ;
    ns1:name "Lithuania" .

<http://example.org/entity/LogRank_P_statistic> a ns1:statistic ;
    ns1:name "Log–Rank P" .

<http://example.org/entity/Luxembourg_Country> a ns1:Country ;
    ns1:name "Luxembourg" .

<http://example.org/entity/Macedonia_Country> a ns1:Country ;
    ns1:name "Macedonia" .

<http://example.org/entity/Malta_Country> a ns1:Country ;
    ns1:name "Malta" .

<http://example.org/entity/Manfred_Gessler_author> a ns1:author ;
    ns1:name "Manfred Gessler" .

<http://example.org/entity/Marciniak_Hospital_Institution> a ns1:Institution ;
    ns1:name "Marciniak Hospital" .

<http://example.org/entity/Marry_M_van_den_Heuvel_Eibrink_author> a ns1:author ;
    ns1:name "Marry M. van den Heuvel-Eibrink" .

<http://example.org/entity/Mitchell_C_author> a ns1:author ;
    ns1:name "Mitchell, C." .

<http://example.org/entity/Monaco_Country> a ns1:Country ;
    ns1:name "Monaco" .

<http://example.org/entity/Montenegro_Country> a ns1:Country ;
    ns1:name "Montenegro" .

<http://example.org/entity/Morocco_Country> a ns1:Country ;
    ns1:name "Morocco" .

<http://example.org/entity/NSS_Surgery_Type> a ns1:Surgery_Type ;
    ns1:name "NSS" .

<http://example.org/entity/NSS_entity> ns2:includes <http://example.org/entity/enucleation_entity>,
        <http://example.org/entity/partial_nephrectomy_entity> .

<http://example.org/entity/NSS_surgical_technique> a ns1:surgical_technique ;
    ns1:name "NSS" .

<http://example.org/entity/NWTS_4_study> a ns1:study ;
    ns1:name "NWTS-4" .

<http://example.org/entity/NWTS_5_relapse_protocol_treatment_protocol> a ns1:treatment_protocol ;
    ns1:name "NWTS-5 relapse protocol" .

<http://example.org/entity/NWTS_5_study> a ns1:study ;
    ns1:name "NWTS-5" .

<http://example.org/entity/National_Wilms_Tumor_Study_Group_study_group> a ns1:study_group ;
    ns1:name "National Wilms Tumor Study Group" .

<http://example.org/entity/Nephron_sparing_surgery_NSS_treatment> a ns1:treatment ;
    ns1:name "Nephron sparing surgery (NSS)" .

<http://example.org/entity/Netherlands_Country> a ns1:Country ;
    ns1:name "Netherlands" .

<http://example.org/entity/Norbert_Graf_author> a ns1:author ;
    ns1:name "Norbert Graf" .

<http://example.org/entity/Norway_Country> a ns1:Country ;
    ns1:name "Norway" .

<http://example.org/entity/OS_Survival_Rate> a ns1:Survival_Rate ;
    ns1:name "OS" .

<http://example.org/entity/OS_probability_measure> a ns1:measure ;
    ns1:name "OS probability" .

<http://example.org/entity/OS_probability_metric> a ns1:metric ;
    ns1:name "OS probability" .

<http://example.org/entity/Ospedale_Pediatrico_Bambino_Ges%C3%B9_Institution> a ns1:Institution ;
    ns1:name "Ospedale Pediatrico Bambino Gesù" .

<http://example.org/entity/Paola_Collini_author> a ns1:author ;
    ns1:name "Paola Collini" .

<http://example.org/entity/Pediatr_Blood_Cancer_55_journal> a ns1:journal ;
    ns1:name "Pediatr. Blood Cancer 55" .

<http://example.org/entity/Pediatr_Blood_Cancer_59_journal> a ns1:journal ;
    ns1:name "Pediatr. Blood Cancer 59" .

<http://example.org/entity/Pediatr_Blood_Cancer_61_journal> a ns1:journal ;
    ns1:name "Pediatr. Blood Cancer 61" .

<http://example.org/entity/Poland_Country> a ns1:Country ;
    ns1:name "Poland" .

<http://example.org/entity/Portugal_Country> a ns1:Country ;
    ns1:name "Portugal" .

<http://example.org/entity/Prinses_Maxima_Centrum_Institution> a ns1:Institution ;
    ns1:name "Prinses Maxima Centrum" .

<http://example.org/entity/Pritchard_Jones_K_author> a ns1:author ;
    ns1:name "Pritchard-Jones, K." .

<http://example.org/entity/Relapsed_Wilms_tumour_condition> a ns1:condition ;
    ns1:name "Relapsed Wilms tumour" .

<http://example.org/entity/Rhoikos_Furtw%C3%A4ngler_author> a ns1:author ;
    ns1:name "Rhoikos Furtwängler" .

<http://example.org/entity/Russia_Country> a ns1:Country ;
    ns1:name "Russia" .

<http://example.org/entity/SIOP2001_Study> a ns1:Study ;
    ns1:name "SIOP−2001" .

<http://example.org/entity/SIOP2001_protocol_medical_protocol> a ns1:medical_protocol ;
    ns1:name "SIOP−2001 protocol" .

<http://example.org/entity/SIOP2001_randomized_controlled_trial_study> a ns1:study ;
    ns1:name "SIOP−2001 randomized controlled trial" .

<http://example.org/entity/SIOP2001_randomized_trial_clinical_trial> a ns1:clinical_trial ;
    ns1:name "SIOP−2001 randomized trial" .

<http://example.org/entity/SIOP9301_trial_trial> a ns1:trial ;
    ns1:name "SIOP−93–01 trial" .

<http://example.org/entity/SIOPRTSG_Organization> a ns1:Organization ;
    ns1:name "SIOP–RTSG" .

<http://example.org/entity/SIOPRTSG_organization> a ns1:organization ;
    ns1:name "SIOP–RTSG" .

<http://example.org/entity/SIOPRTSG_panel_organization> a ns1:organization ;
    ns1:name "SIOP−RTSG panel" .

<http://example.org/entity/SIOP_2001_trial_trial> a ns1:trial ;
    ns1:name "SIOP-2001 trial" .

<http://example.org/entity/SIOP_9301_trial_trial> a ns1:trial ;
    ns1:name "SIOP 93–01 trial" .

<http://example.org/entity/SIOP_database_database> a ns1:database ;
    ns1:name "SIOP database" .

<http://example.org/entity/SIOP_organization> a ns1:organization ;
    ns1:name "SIOP" .

<http://example.org/entity/San_Marino_Country> a ns1:Country ;
    ns1:name "San Marino" .

<http://example.org/entity/Serbia_Country> a ns1:Country ;
    ns1:name "Serbia" .

<http://example.org/entity/Slovakia_Country> a ns1:Country ;
    ns1:name "Slovakia" .

<http://example.org/entity/Slovenia_Country> a ns1:Country ;
    ns1:name "Slovenia" .

<http://example.org/entity/Smets_A_M_author> a ns1:author ;
    ns1:name "Smets, A. M." .

<http://example.org/entity/Spain_Country> a ns1:Country ;
    ns1:name "Spain" .

<http://example.org/entity/Spreafico_F_author> a ns1:author ;
    ns1:name "Spreafico, F." .

<http://example.org/entity/St_Anna_KinderspitalCCRI_Institution> a ns1:Institution ;
    ns1:name "St. Anna Kinderspital/CCRI" .

<http://example.org/entity/Sweden_Country> a ns1:Country ;
    ns1:name "Sweden" .

<http://example.org/entity/Switzerland_Country> a ns1:Country ;
    ns1:name "Switzerland" .

<http://example.org/entity/Terenziani_M_author> a ns1:author ;
    ns1:name "Terenziani, M." .

<http://example.org/entity/Tournade_M_F_author> a ns1:author ;
    ns1:name "Tournade, M. F." .

<http://example.org/entity/Tunisia_Country> a ns1:Country ;
    ns1:name "Tunisia" .

<http://example.org/entity/Turkey_Country> a ns1:Country ;
    ns1:name "Turkey" .

<http://example.org/entity/UKW3_trial_clinical_trial> a ns1:clinical_trial ;
    ns1:name "UKW3 trial" .

<http://example.org/entity/UKW3_trial_trial> a ns1:trial ;
    ns1:name "UKW3 trial" .

<http://example.org/entity/UKW_R_protocol_treatment_protocol> a ns1:treatment_protocol ;
    ns1:name "UKW-R protocol" .

<http://example.org/entity/UK_Childrens_Cancer_Study_Group_study_group> a ns1:study_group ;
    ns1:name "UK Children’s Cancer Study Group" .

<http://example.org/entity/UK_Childrens_Cancer_and_Leukaemia_Group_UKCCLG_organization> a ns1:organization ;
    ns1:name "UK Children’s Cancer and Leukaemia Group (UKCCLG)" .

<http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_medical_protocol> a ns1:medical_protocol ;
    ns1:name "UMBRELLA SIOP–RTSG 2016 protocol" .

<http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_protocol> a ns1:protocol ;
    ns1:name "UMBRELLA SIOP-RTSG 2016 protocol" .

<http://example.org/entity/UMBRELLA_SIOP_RTSG_2016_protocol_source> a ns1:source ;
    ns1:name "UMBRELLA-SIOP-RTSG-2016 protocol" .

<http://example.org/entity/UMBRELLA_protocol_Project> a ns1:Project ;
    ns1:name "UMBRELLA protocol" .

<http://example.org/entity/UMBRELLA_protocol_Protocol> a ns1:Protocol ;
    ns1:name "UMBRELLA protocol" .

<http://example.org/entity/UMBRELLA_protocol_protocol> a ns1:protocol ;
    ns1:name "UMBRELLA protocol" .

<http://example.org/entity/UMBRELLA_protocol_treatment_protocol> a ns1:treatment_protocol ;
    ns1:name "UMBRELLA protocol" .

<http://example.org/entity/United_Kingdom_Country> a ns1:Country ;
    ns1:name "United Kingdom" .

<http://example.org/entity/University_Hospital_Homburg_Institution> a ns1:Institution ;
    ns1:name "University Hospital Homburg" .

<http://example.org/entity/University_Hospital_of_Munich_Institution> a ns1:Institution ;
    ns1:name "University Hospital of Munich" .

<http://example.org/entity/University_Hospital_of_Tuebingen_Institution> a ns1:Institution ;
    ns1:name "University Hospital of Tuebingen" .

<http://example.org/entity/Verschuur_A_author> a ns1:author ;
    ns1:name "Verschuur, A." .

<http://example.org/entity/Vincristine_drug> a ns1:drug ;
    ns1:name "Vincristine" .

<http://example.org/entity/Warmann_S_W_author> a ns1:author ;
    ns1:name "Warmann, S. W." .

<http://example.org/entity/Weirich_A_author> a ns1:author ;
    ns1:name "Weirich, A." .

<http://example.org/entity/Wilms_tumour_clinical_condition> a ns1:clinical_condition ;
    ns1:name "Wilms tumour" .

<http://example.org/entity/Wilms_tumour_condition> a ns1:condition ;
    ns1:name "Wilms tumour" .

<http://example.org/entity/Wilms_tumour_disease> a ns1:disease ;
    ns1:name "Wilms tumour" .

<http://example.org/entity/Wilms_tumour_histology_classification> a ns1:classification ;
    ns1:name "Wilms tumour histology" .

<http://example.org/entity/Wilms_tumours_Disease> a ns1:Disease ;
    ns1:name "Wilms tumours" .

<http://example.org/entity/Wilms_tumours_condition> a ns1:condition ;
    ns1:name "Wilms tumours" .

<http://example.org/entity/actinomycin_D_drug> a ns1:drug ;
    ns1:name "actinomycin D" .

<http://example.org/entity/actinomycin_D_medication> a ns1:medication ;
    ns1:name "actinomycin D" .

<http://example.org/entity/adult_Wilms_tumours_disease> a ns1:disease ;
    ns1:name "adult Wilms tumours" .

<http://example.org/entity/autologous_stem_cell_rescue_ASCR_treatment> a ns1:treatment ;
    ns1:name "autologous stem cell rescue (ASCR)" .

<http://example.org/entity/blastemal_component_medical_term> a ns1:medical_term ;
    ns1:name "blastemal component" .

<http://example.org/entity/blastemal_type_Wilms_tumour_clinical_condition> a ns1:clinical_condition ;
    ns1:name "blastemal-type Wilms tumour" .

<http://example.org/entity/blastemal_type_Wilms_tumours_condition_subcategory> a ns1:condition_subcategory ;
    ns1:name "blastemal-type Wilms tumours" .

<http://example.org/entity/camptothecins_irinotecan_or_topotecan_treatment> a ns1:treatment ;
    ns1:name "camptothecins (irinotecan or topotecan)" .

<http://example.org/entity/carboplatin_and_etoposide_treatment> a ns1:treatment ;
    ns1:name "carboplatin and etoposide" .

<http://example.org/entity/carboplatin_drug> a ns1:drug ;
    ns1:name "carboplatin" .

<http://example.org/entity/chemotherapy_resistant_disease_condition_detail> a ns1:condition_detail ;
    ns1:name "chemotherapy-resistant disease" .

<http://example.org/entity/chemotherapy_treatment> a ns1:treatment ;
    ns1:name "chemotherapy" .

<http://example.org/entity/chemotherapy_treatment_method> a ns1:treatment_method ;
    ns1:name "chemotherapy" .

<http://example.org/entity/clear_cell_sarcoma_of_the_kidney_CCSK_clinical_condition> a ns1:clinical_condition ;
    ns1:name "clear cell sarcoma of the kidney (CCSK)" .

<http://example.org/entity/clear_cell_sarcoma_of_the_kidney_disease> a ns1:disease ;
    ns1:name "clear cell sarcoma of the kidney" .

<http://example.org/entity/complete_remission_treatment_response> a ns1:treatment_response ;
    ns1:name "complete remission" .

<http://example.org/entity/completely_necrotic_metastasis_condition_detail> a ns1:condition_detail ;
    ns1:name "completely necrotic metastasis" .

<http://example.org/entity/confirm_metastatic_disease_by_histology_treatment> a ns1:treatment ;
    ns1:name "confirm metastatic disease by histology" .

<http://example.org/entity/congenital_mesoblastic_nephroma_CMN_clinical_condition> a ns1:clinical_condition ;
    ns1:name "congenital mesoblastic nephroma (CMN)" .

<http://example.org/entity/congenital_mesoblastic_nephroma_disease> a ns1:disease ;
    ns1:name "congenital mesoblastic nephroma" .

<http://example.org/entity/cyclophosphamide_and_etoposide_treatment> a ns1:treatment ;
    ns1:name "cyclophosphamide and etoposide" .

<http://example.org/entity/cyclophosphamide_drug> a ns1:drug ;
    ns1:name "cyclophosphamide" .

<http://example.org/entity/de_Kraker_J_author> a ns1:author ;
    ns1:name "de Kraker, J." .

<http://example.org/entity/doxorubicin_drug> a ns1:drug ;
    ns1:name "doxorubicin" .

<http://example.org/entity/doxorubicin_medication> a ns1:medication ;
    ns1:name "doxorubicin" .

<http://example.org/entity/enucleation_surgical_technique> a ns1:surgical_technique ;
    ns1:name "enucleation" .

<http://example.org/entity/epithelial_tumour_types_clinical_condition> a ns1:clinical_condition ;
    ns1:name "epithelial tumour types" .

<http://example.org/entity/etoposide_drug> a ns1:drug ;
    ns1:name "etoposide" .

<http://example.org/entity/event_free_survival_EFS_outcome> a ns1:outcome ;
    ns1:name "event-free survival (EFS)" .

<http://example.org/entity/flank_Anatomical_Structure> a ns1:Anatomical_Structure ;
    ns1:name "flank" .

<http://example.org/entity/focal_anaplasia_type_tumours_clinical_condition> a ns1:clinical_condition ;
    ns1:name "focal anaplasia-type tumours" .

<http://example.org/entity/genomic_changes_biological_factor> a ns1:biological_factor ;
    ns1:name "genomic changes" .

<http://example.org/entity/high_dose_chemotherapy_treatment> a ns1:treatment ;
    ns1:name "high-dose chemotherapy" .

<http://example.org/entity/high_risk_Risk_Category> a ns1:Risk_Category ;
    ns1:name "high-risk" .

<http://example.org/entity/high_risk_disease_classification_subgroup> a ns1:classification_subgroup ;
    ns1:name "high-risk disease" .

<http://example.org/entity/high_risk_disease_entity> ns2:is_a_type_of <http://example.org/entity/Wilms_tumour_histology_entity> .

<http://example.org/entity/ifosfamide_treatment> a ns1:treatment ;
    ns1:name "ifosfamide" .

<http://example.org/entity/infant_Wilms_tumours_disease> a ns1:disease ;
    ns1:name "infant Wilms tumours" .

<http://example.org/entity/intermediate_risk_Risk_Category> a ns1:Risk_Category ;
    ns1:name "intermediate-risk" .

<http://example.org/entity/intermediate_risk_disease_classification_subgroup> a ns1:classification_subgroup ;
    ns1:name "intermediate-risk disease" .

<http://example.org/entity/laparoscopic_surgery_Surgery_Type> a ns1:Surgery_Type ;
    ns1:name "laparoscopic surgery" .

<http://example.org/entity/large_volume_tumours_clinical_condition> a ns1:clinical_condition ;
    ns1:name "large-volume tumours" .

<http://example.org/entity/large_volume_tumours_entity> ns2:associated_with_decreased <http://example.org/entity/event_free_survival_EFS_entity> .

<http://example.org/entity/locoregional_disease_Disease_Category> a ns1:Disease_Category ;
    ns1:name "locoregional disease" .

<http://example.org/entity/low_risk_Risk_Category> a ns1:Risk_Category ;
    ns1:name "low-risk" .

<http://example.org/entity/low_risk_disease_classification_subgroup> a ns1:classification_subgroup ;
    ns1:name "low-risk disease" .

<http://example.org/entity/low_risk_disease_entity> ns2:is_a_type_of <http://example.org/entity/Wilms_tumour_histology_entity> .

<http://example.org/entity/lung_nodules_35mm_condition_detail> a ns1:condition_detail ;
    ns1:name "lung nodules 3–5mm" .

<http://example.org/entity/lung_nodules_5mm_condition_detail> a ns1:condition_detail ;
    ns1:name "lung nodules >5mm" .

<http://example.org/entity/malignant_rhabdoid_tumour_of_the_kidney_MRTK_clinical_condition> a ns1:clinical_condition ;
    ns1:name "malignant rhabdoid tumour of the kidney (MRTK)" .

<http://example.org/entity/malignant_rhabdoid_tumour_of_the_kidney_disease> a ns1:disease ;
    ns1:name "malignant rhabdoid tumour of the kidney" .

<http://example.org/entity/malignant_rhabdoid_tumours_disease> a ns1:disease ;
    ns1:name "malignant rhabdoid tumours" .

<http://example.org/entity/metastasis_surgery_treatment> a ns1:treatment ;
    ns1:name "metastasis surgery" .

<http://example.org/entity/metastatic_disease_Disease_Category> a ns1:Disease_Category ;
    ns1:name "metastatic disease" .

<http://example.org/entity/metastatic_disease_stage_IV_clinical_condition> a ns1:clinical_condition ;
    ns1:name "metastatic disease (stage IV)" .

<http://example.org/entity/metastatic_sites_Anatomical_Structure> a ns1:Anatomical_Structure ;
    ns1:name "metastatic sites" .

<http://example.org/entity/minimally_invasive_surgery_Surgery_Type> a ns1:Surgery_Type ;
    ns1:name "minimally invasive surgery" .

<http://example.org/entity/mixed_clinical_condition> a ns1:clinical_condition ;
    ns1:name "mixed" .

<http://example.org/entity/no_evidence_of_metastasis_condition_detail> a ns1:condition_detail ;
    ns1:name "no evidence of metastasis" .

<http://example.org/entity/no_evidence_of_viable_tumour_condition_detail> a ns1:condition_detail ;
    ns1:name "no evidence of viable tumour" .

<http://example.org/entity/non_Wilms_tumours_disease> a ns1:disease ;
    ns1:name "non-Wilms tumours" .

<http://example.org/entity/novel_compounds_treatment_option> a ns1:treatment_option ;
    ns1:name "novel compounds" .

<http://example.org/entity/overall_survival_outcome> a ns1:outcome ;
    ns1:name "overall survival" .

<http://example.org/entity/partial_nephrectomy_surgical_technique> a ns1:surgical_technique ;
    ns1:name "partial nephrectomy" .

<http://example.org/entity/partial_response_treatment_response> a ns1:treatment_response ;
    ns1:name "partial response" .

<http://example.org/entity/preoperative_chemotherapy_treatment> a ns1:treatment ;
    ns1:name "preoperative chemotherapy" .

<http://example.org/entity/progressive_disease_treatment_response> a ns1:treatment_response ;
    ns1:name "progressive disease" .

<http://example.org/entity/proton_therapy_Treatment> a ns1:Treatment ;
    ns1:name "proton therapy" .

<http://example.org/entity/proton_therapy_entity> ns2:to_be_investigated_for <http://example.org/entity/UMBRELLA_protocol_entity> .

<http://example.org/entity/pulmonary_radiotherapy_Treatment> a ns1:Treatment ;
    ns1:name "pulmonary radiotherapy" .

<http://example.org/entity/radiotherapy_Treatment> a ns1:Treatment ;
    ns1:name "radiotherapy" .

<http://example.org/entity/radiotherapy_treatment> a ns1:treatment ;
    ns1:name "radiotherapy" .

<http://example.org/entity/radiotherapy_treatment_method> a ns1:treatment_method ;
    ns1:name "radiotherapy" .

<http://example.org/entity/relapsing_patients_patient_group> a ns1:patient_group ;
    ns1:name "relapsing patients" .

<http://example.org/entity/renal_cell_carcinoma_RCC_clinical_condition> a ns1:clinical_condition ;
    ns1:name "renal cell carcinoma (RCC)" .

<http://example.org/entity/renal_cell_carcinoma_disease> a ns1:disease ;
    ns1:name "renal cell carcinoma" .

<http://example.org/entity/renal_tumour_patients_patient_group> a ns1:patient_group ;
    ns1:name "renal tumour patients" .

<http://example.org/entity/renal_tumours_disease> a ns1:disease ;
    ns1:name "renal tumours" .

<http://example.org/entity/representative_nodule_resection_treatment> a ns1:treatment ;
    ns1:name "representative nodule resection" .

<http://example.org/entity/small_volume_tumours_clinical_condition> a ns1:clinical_condition ;
    ns1:name "small-volume tumours" .

<http://example.org/entity/stable_disease_treatment_response> a ns1:treatment_response ;
    ns1:name "stable disease" .

<http://example.org/entity/stage_IIIII_regressive_clinical_condition> a ns1:clinical_condition ;
    ns1:name "stage II–III regressive" .

<http://example.org/entity/stage_IV_WT_condition> a ns1:condition ;
    ns1:name "stage IV WT" .

<http://example.org/entity/stromal_tumour_types_clinical_condition> a ns1:clinical_condition ;
    ns1:name "stromal tumour types" .

<http://example.org/entity/surgery_treatment> a ns1:treatment ;
    ns1:name "surgery" .

<http://example.org/entity/surgery_treatment_method> a ns1:treatment_method ;
    ns1:name "surgery" .

<http://example.org/entity/surgical_complete_resection_treatment> a ns1:treatment ;
    ns1:name "surgical complete resection" .

<http://example.org/entity/van_den_Heuvel_Eibrink_M_M_author> a ns1:author ;
    ns1:name "van den Heuvel-Eibrink, M. M." .

<http://example.org/entity/very_good_partial_remission_treatment_response> a ns1:treatment_response ;
    ns1:name "very good partial remission" .

<http://example.org/entity/viable_metastasis_condition_detail> a ns1:condition_detail ;
    ns1:name "viable metastasis" .

<http://example.org/entity/vincristine_and_actinomycin_D_plus_doxorubicin_treatment> a ns1:treatment ;
    ns1:name "vincristine and actinomycin D plus doxorubicin" .

<http://example.org/entity/vincristine_and_actinomycin_D_treatment> a ns1:treatment ;
    ns1:name "vincristine and actinomycin D" .

<http://example.org/entity/vincristine_drug> a ns1:drug ;
    ns1:name "vincristine" .

<http://example.org/entity/vincristine_medication> a ns1:medication ;
    ns1:name "vincristine" .

<http://example.org/entity/whole_abdominal_radiotherapy_Treatment> a ns1:Treatment ;
    ns1:name "whole-abdominal radiotherapy" .

<http://example.org/entity/whole_lung_irradiation_Treatment> a ns1:Treatment ;
    ns1:name "whole-lung irradiation" .

<http://example.org/entity/wwwsiop_rtsgeu_website> a ns1:website ;
    ns1:name "www.siop-rtsg.eu" .

<http://example.org/entity/UKW3_trial_entity> ns2:focused_on <http://example.org/entity/preoperative_actinomycin_D_and_vincristine_entity> .

<http://example.org/entity/UMBRELLA_SIOPRTSG_2016_protocol_entity> ns2:addresses <http://example.org/entity/non_Wilms_tumours_entity> ;
    ns2:evaluates <http://example.org/entity/genomic_changes_entity> ;
    ns2:evaluates_after <http://example.org/entity/blastemal_component_entity> ;
    ns2:focuses_on <http://example.org/entity/Wilms_tumour_entity> .

<http://example.org/entity/chemotherapy_entity> ns2:used_for <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/doxorubicin_entity> ns2:associated_with_improved_outcome <http://example.org/entity/large_volume_tumours_entity> .

<http://example.org/entity/surgery_entity> ns2:used_for <http://example.org/entity/Wilms_tumours_entity> .

<http://example.org/entity/UMBRELLA_protocol_entity> ns2:adopts_classification_system_from <http://example.org/entity/NSS_entity> ;
    ns2:covers <http://example.org/entity/over_50_countries_entity> ;
    ns2:focuses_on <http://example.org/entity/Wilms_tumours_entity> ;
    ns2:guides <http://example.org/entity/Wilms_tumour_treatment_entity> ;
    ns2:implemented_in <http://example.org/entity/Europe_entity> ;
    ns2:provides_guidelines_for <http://example.org/entity/chemotherapy_entity>,
        <http://example.org/entity/radiotherapy_entity>,
        <http://example.org/entity/surgery_entity> ;
    ns2:treatment_for <http://example.org/entity/Relapsed_Wilms_tumour_entity> .

<http://example.org/entity/Wilms_tumour_entity> ns2:treatment_involves <http://example.org/entity/chemotherapy_entity>,
        <http://example.org/entity/radiotherapy_entity>,
        <http://example.org/entity/surgery_entity> .

<http://example.org/entity/radiotherapy_entity> ns2:used_for <http://example.org/entity/Wilms_tumours_entity> .

